| Joe D Sagely, DO | |
|
235 W 6th St, Chelsea, OK 74016-1833 | |
| (918) 789-3146 | |
| (844) 560-1455 |
| Full Name | Joe D Sagely |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 36 Years |
| Location | 235 W 6th St, Chelsea, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255321162 | NPI | - | NPPES |
| 10071600A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 2809 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Homestead Medical Clinic, Plc | 6204065196 | 2 |
News Archive
Danaher Corporation today announced results for the third quarter of 2013. All financial metrics in this release reflect only the Company's continuing operations and all references to increases in financial metrics reflect year-over-year changes, unless otherwise noted.
Legal-Bay LLC, The Lawsuit Settlement Funding Company, reported today that a Philadelphia jury returned a $13.5 million verdict against Johnson & Johnson's Ethicon subsidiary on Wednesday, making this the second substantial verdict award in favor of the plaintiffs in recent months.
A BLOOD test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing, according to a study published in the journal Cancer Discovery today (Monday).
Bayer HealthCare Pharmaceuticals Inc. announced today that the Peripheral and Central Nervous System Drugs Advisory Committee to the U.S. Food and Drug Administration voted unanimously that clinical trial and postmarketing data for gadobutrol injection, a macrocyclic 1.0 molar gadolinium-based contrast agent (GBCA), support approval of the product for proposed use in diagnostic magnetic resonance imaging (MRI) in adults and children.
Perhaps you think of allergies as being most bothersome- and most likely to occur- during the spring and summer months, when pollens and molds are seemingly everywhere.
› Verified 7 days ago
| Entity Name | Homestead Medical Clinic, Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750718730 PECOS PAC ID: 6204065196 Enrollment ID: O20140219001433 |
News Archive
Danaher Corporation today announced results for the third quarter of 2013. All financial metrics in this release reflect only the Company's continuing operations and all references to increases in financial metrics reflect year-over-year changes, unless otherwise noted.
Legal-Bay LLC, The Lawsuit Settlement Funding Company, reported today that a Philadelphia jury returned a $13.5 million verdict against Johnson & Johnson's Ethicon subsidiary on Wednesday, making this the second substantial verdict award in favor of the plaintiffs in recent months.
A BLOOD test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing, according to a study published in the journal Cancer Discovery today (Monday).
Bayer HealthCare Pharmaceuticals Inc. announced today that the Peripheral and Central Nervous System Drugs Advisory Committee to the U.S. Food and Drug Administration voted unanimously that clinical trial and postmarketing data for gadobutrol injection, a macrocyclic 1.0 molar gadolinium-based contrast agent (GBCA), support approval of the product for proposed use in diagnostic magnetic resonance imaging (MRI) in adults and children.
Perhaps you think of allergies as being most bothersome- and most likely to occur- during the spring and summer months, when pollens and molds are seemingly everywhere.
› Verified 7 days ago
| Entity Name | Medexpress Urgent Care, Pc - Oklahoma |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033517248 PECOS PAC ID: 3678893138 Enrollment ID: O20150522002040 |
News Archive
Danaher Corporation today announced results for the third quarter of 2013. All financial metrics in this release reflect only the Company's continuing operations and all references to increases in financial metrics reflect year-over-year changes, unless otherwise noted.
Legal-Bay LLC, The Lawsuit Settlement Funding Company, reported today that a Philadelphia jury returned a $13.5 million verdict against Johnson & Johnson's Ethicon subsidiary on Wednesday, making this the second substantial verdict award in favor of the plaintiffs in recent months.
A BLOOD test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing, according to a study published in the journal Cancer Discovery today (Monday).
Bayer HealthCare Pharmaceuticals Inc. announced today that the Peripheral and Central Nervous System Drugs Advisory Committee to the U.S. Food and Drug Administration voted unanimously that clinical trial and postmarketing data for gadobutrol injection, a macrocyclic 1.0 molar gadolinium-based contrast agent (GBCA), support approval of the product for proposed use in diagnostic magnetic resonance imaging (MRI) in adults and children.
Perhaps you think of allergies as being most bothersome- and most likely to occur- during the spring and summer months, when pollens and molds are seemingly everywhere.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joe D Sagely, DO Po Box 218, Chelsea, OK 74016-0218 Ph: (918) 789-3146 | Joe D Sagely, DO 235 W 6th St, Chelsea, OK 74016-1833 Ph: (918) 789-3146 |
News Archive
Danaher Corporation today announced results for the third quarter of 2013. All financial metrics in this release reflect only the Company's continuing operations and all references to increases in financial metrics reflect year-over-year changes, unless otherwise noted.
Legal-Bay LLC, The Lawsuit Settlement Funding Company, reported today that a Philadelphia jury returned a $13.5 million verdict against Johnson & Johnson's Ethicon subsidiary on Wednesday, making this the second substantial verdict award in favor of the plaintiffs in recent months.
A BLOOD test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing, according to a study published in the journal Cancer Discovery today (Monday).
Bayer HealthCare Pharmaceuticals Inc. announced today that the Peripheral and Central Nervous System Drugs Advisory Committee to the U.S. Food and Drug Administration voted unanimously that clinical trial and postmarketing data for gadobutrol injection, a macrocyclic 1.0 molar gadolinium-based contrast agent (GBCA), support approval of the product for proposed use in diagnostic magnetic resonance imaging (MRI) in adults and children.
Perhaps you think of allergies as being most bothersome- and most likely to occur- during the spring and summer months, when pollens and molds are seemingly everywhere.
› Verified 7 days ago